- Home
- ESPR vs DENN Comparison
ESPR vs DENN Comparison
Compare ESPR & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- DENN
- Stock Information
- Founded
- ESPR 2008
- DENN 1953
- Country
- ESPR United States
- DENN United States
- Employees
- ESPR N/A
- DENN 3500
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- DENN Restaurants
- Sector
- ESPR Health Care
- DENN Consumer Discretionary
- Exchange
- ESPR Nasdaq
- DENN Nasdaq
- Market Cap
- ESPR 305.0M
- DENN 203.4M
- IPO Year
- ESPR 2013
- DENN 1989
- Fundamental
- Price
- ESPR $1.69
- DENN $3.91
- Analyst Decision
- ESPR Buy
- DENN Strong Buy
- Analyst Count
- ESPR 7
- DENN 6
- Target Price
- ESPR $6.36
- DENN $7.75
- AVG Volume (30 Days)
- ESPR 4.2M
- DENN 1.5M
- Earning Date
- ESPR 03-04-2025
- DENN 04-29-2025
- Dividend Yield
- ESPR N/A
- DENN N/A
- EPS Growth
- ESPR N/A
- DENN 17.14
- EPS
- ESPR N/A
- DENN 0.41
- Revenue
- ESPR $332,314,000.00
- DENN $452,334,000.00
- Revenue This Year
- ESPR $5.51
- DENN $5.81
- Revenue Next Year
- ESPR $1.42
- DENN $2.50
- P/E Ratio
- ESPR N/A
- DENN $9.59
- Revenue Growth
- ESPR 185.66
- DENN N/A
- 52 Week Low
- ESPR $1.47
- DENN $3.80
- 52 Week High
- ESPR $3.94
- DENN $9.25
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- DENN 28.29
- Support Level
- ESPR $1.47
- DENN $3.80
- Resistance Level
- ESPR $1.61
- DENN $4.11
- Average True Range (ATR)
- ESPR 0.12
- DENN 0.20
- MACD
- ESPR 0.02
- DENN 0.02
- Stochastic Oscillator
- ESPR 56.41
- DENN 14.47
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.